About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half ...
Most adults (62%) say they have taken a GLP-1 drug to treat a chronic condition including diabetes or heart disease, while 43 ...
Injected medications that treat diabetes and obesity increase the risk of a rare but serious side effect: stomach paralysis, ...
Sales of anti-obesity drugs hit $1.1 billion in the second quarter of 2023.
A NEW weight loss drug could hijack the brain like a ‘Trojan horse’ to double weight loss. The drug could help the body to ...
Agents in development would preserve lean body mass and further promote fat loss in people taking new antiobesity medications ...
The number of young people in the US who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic for weight loss and ...
Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and ...
Wegovy, Ozempic and now retatrutide – the ‘miracle’ drugs are booming, but are they safe and how do they stack up?
Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that ...
Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of meals for people ...
Drug Stocks latest news, photos, videos, breaking news, special reports, blogs, and updates from Business Insider India ...